Thursday 9/10 Insider Buying Report: RCKY, RCUS

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.

So let's look at two noteworthy recent insider buys.

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.

So let's look at two noteworthy recent insider buys.

At Rocky Brands, a filing with the SEC revealed that on Thursday, Director Robert Burton Moore Jr. purchased 6,582 shares of RCKY, at a cost of $25.34 each, for a total investment of $166,785.

Rocky Brands is trading up about 2.3% on the day Thursday.

Before this latest buy, Moore Jr. made one other purchase in the past twelve months, buying $41,700 shares for a cost of $27.80 a piece.

And on Wednesday, Chief Financial Officer Robert C.

Goeltz II purchased $107,848 worth of Arcus Biosciences, purchasing 5,000 shares at a cost of $21.57 each.

Arcus Biosciences is trading up about 7.9% on the day Thursday.

So far Goeltz II is in the green, up about 9.9% on their buy based on today's trading high of $23.70.